Krebs Biochem Standalone September 2025 Net Sales at Rs 4.17 crore, down 67.58% Y-o-Y
Broker Research
November 10, 2025 / 12:53 IST
Reported Standalone quarterly numbers for Krebs Biochemicals & Industries are: Net Sales at Rs 4.17 crore in September 2025 down 67.58% from Rs. 12.86 crore in September 2024. Quarterly Net Loss at Rs. 6.14 crore in September 2025 down 6.63% from Rs. 5.76 crore in September 2024. EBITDA stands negative at Rs. 2.79 crore in September 2025 down 6.08% from Rs. 2.63 crore in September 2024. Krebs Biochem shares closed at 68.69 on November 06, 2025 (NSE) and has given -5.90% returns over the last 6 months and -24.22% over the last 12 months.
| Krebs Biochemicals & Industries | | Standalone Quarterly Results | in Rs. Cr. |
|
Story continues below Advertisement
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 4.17 | 5.48 | 12.86 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 4.17 | 5.48 | 12.86 | | EXPENDITURE | | Consumption of Raw Materials | 0.00 | 0.04 | 1.03 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | 0.25 | 1.39 | | Power & Fuel | -- | -- | -- | | Employees Cost | 2.69 | 2.75 | 4.39 | | Depreciation | 1.62 | 1.60 | 1.71 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 4.27 | 4.53 | 8.75 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -4.42 | -3.69 | -4.42 | | Other Income | 0.01 | 0.01 | 0.09 | | P/L Before Int., Excpt. Items & Tax | -4.41 | -3.67 | -4.34 | | Interest | 1.73 | 1.65 | 1.42 | | P/L Before Exceptional Items & Tax | -6.14 | -5.32 | -5.76 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -6.14 | -5.32 | -5.76 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -6.14 | -5.32 | -5.76 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -6.14 | -5.32 | -5.76 | | Equity Share Capital | 21.56 | 21.56 | 21.56 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.85 | -2.47 | -2.67 | | Diluted EPS | -2.85 | -2.47 | -2.67 | | EPS After Extra Ordinary | | Basic EPS | -2.85 | -2.47 | -2.67 | | Diluted EPS | -2.85 | -2.47 | -2.67 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
